Related Experiment Video

Updated: Jun 21, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.3K

Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma

Vivian Zhou1, Manya Yu1,2, Jiaqi Fu2

  • 1Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.

Journal of Translational Medicine
|July 8, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.8K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K

Related Experiment Videos

Last Updated: Jun 21, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.3K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.8K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

Articles linked to this work by shared authors, journal, and citation graph.

Efficient Production of Cyanidin 3-O-Glucoside and Cyanidin 3-O-Rutinoside in Escherichia coli via Metabolic Engineering and Process Optimization.

Journal of agricultural and food chemistry·2026

Germline Genomic and DNA Methylation Differences Between MGUS and Multiple Myeloma Among Patients of African Ancestry.

Cells·2026

Advances in Living Cell-Mediated Nanodrug Delivery Systems: Construction Strategies, Applications and Challenges.

Pharmaceutics·2026

CLDN18.2 targeting enhances chemotherapy sensitivity in pancreatic cancer cells and lung cancer organoids.

Biochemical and biophysical research communications·2026

Organic Activatable Afterglow Imaging Probes: From Molecular Design to Biomedical Translation.

Angewandte Chemie (International ed. in English)·2026

Coxiella burnetii inhibits host cell death by ubiquitination-induced inactivation of an apoptosis nuclease.

mLife·2026

SPP1⁺ macrophage-derived WNT5A contributes to MMP11⁺ myCAF-mediated matrix remodeling and immunotherapy resistance in lung adenocarcinoma.

Journal of translational medicine·2026

Engineering human endogenous retrovirus-K for improving immunogenicity and broad cancer targeting.

Journal of translational medicine·2026

Temporal interference stimulation rescues dopaminergic neurons in the substantia nigra of MPTP-induced Parkinson's disease mice via inhibition of lipid peroxidation.

Journal of translational medicine·2026

BRAP maintains SEC24D stability to regulate ER stress and promote cervical adenocarcinoma progression.

Journal of translational medicine·2026

Macrophage-derived exosomes in bone tissue regeneration: spatiotemporal immunomodulation, engineering advances, and translational frontiers.

Journal of translational medicine·2026

Single-cell transcriptomics reveals macrophage-neutrophil crosstalk in Haematitum-induced lung injury associated with gut dysbiosis.

Journal of translational medicine·2026

Deubiquitinase USP5 suppresses ferroptosis in lung adenocarcinoma by deubiquitinating and stabilizing GPX3.

Journal of cell communication and signaling·2026

Single-Cell Transcriptomics Reveals Rora-Associated Aberrant Granulosa Cell Differentiation in Polycystic Ovary Syndrome.

International journal of women's health·2026

Tachy-paced cardiomyocyte-derived small extracellular vesicles impair SERCA2a-dependent Ca2+ handling in recipient cardiomyocytes.

Journal of molecular and cellular cardiology plus·2026

THE DOUBLE-EDGED SWORD OF ANDROGEN SIGNALING FOR SELECTIVE RADIOSENSITIZATION OF PROSTATE CANCER CELLS.

Transactions of the American Clinical and Climatological Association·2026

CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids.

Global medical genetics·2026

Core needle biopsy-derived breast cancer microtumors enable functional drug-response testing for precision oncology.

iScience·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us